ABBV Technical Analysis

As of date:	9/22/2022
ABBV stock price:	143.01
ABBV 50 DMA:	142.27
ABBV 200 DMA:	143.92
ABBV MACD (200-50):	1.65
ABBV RSI:	59.57

Extremely Overbought
	59.57
Extremely Oversold

Also see:
ABBV Market Cap History
ABBV Shares Outstanding History
ABBV YTD Return

Quotes delayed 20 minutes

Free ABBV Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

FXH Getting Very Oversold
2 hours, 18 minutes ago

FXG Crosses Critical Technical Indicator
2 hours, 20 minutes ago

Shares of FXE Now Oversold
2 hours, 22 minutes ago

Shares of FVD Now Oversold
2 hours, 22 minutes ago

FTLS Enters Oversold Territory
2 hours, 25 minutes ago

GasLog Partners (GLOP) Shares Cross Below 200 DMA
2 hours, 25 minutes ago

Antero Resources (AR) Shares Cross Below 200 DMA
2 hours, 27 minutes ago

FTEC Getting Very Oversold
2 hours, 27 minutes ago

FNDX Getting Very Oversold
2 hours, 37 minutes ago

Sisecam Resources (SIRE) Shares Cross Below 200 DMA
2 hours, 37 minutes ago

FNDF Enters Oversold Territory
2 hours, 37 minutes ago

Shares of FNDB Now Oversold
2 hours, 37 minutes ago

Western Midstream Partners Breaks Below 200-Day Moving Average - Notable for WES
2 hours, 44 minutes ago

UAN Crosses Below Key Moving Average Level
2 hours, 44 minutes ago

ARCO Makes Notable Cross Below Critical Moving Average
2 hours, 44 minutes ago

More Technical Analysis News

AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.

When researching a stock like AbbVie, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from ABBV Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for ABBV stock — the real life supply and demand for the stock over time — and examines that data in different ways.

10 Most Oversold S&P 500 Stocks

10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying

10 ETFs With Most Upside To Targets

The DividendRank Top 25

Warren Buffett Dividend Stocks

10 Cheap Dividend Stocks Under $10

10 Top DividendRank'ed Energy Stocks

The 10 Highest Yielding Preferred Stocks

The 15 Most Active S&P Call & Put Options

Video: Technical Analysis

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

AbbVie (ABBV) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

ABC Technical Analysis
ABMD Technical Analysis
ABT Technical Analysis
ALGN Technical Analysis
AMGN Technical Analysis
BAX Technical Analysis
BDX Technical Analysis
BIIB Technical Analysis
BIO Technical Analysis
BMY Technical Analysis
More Healthcare companies »

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.

ABBV Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2022, All Rights Reserved